Stories
At the heart of every company we support is a team with bold visions and deep convictions, turning science into meaningful and measurable impact.
”
”Organ transplantation saves and radically improves lives. Approximately 100,000 men, women and children in the United States are on the national transplant waiting list with a new patient added every ten minutes. OrganOx is committed to using our Normothermic Machine Perfusion technology to make organs more widely available to patients who need them around the world. We are thrilled at the prospect of working closely with Lauxera to take OrganOx to new heights in the US and ROW.
Craig MarshallCEO at OrganOx
”After interacting with numerous investment firms, we decided to partner with Lauxera because of their deep experience developing and commercializing medical devices, their humility, ‘can-do’ attitude, and strong links to the US market. It felt like a true partnership from the first day Lauxera started due diligence and we are excited to build our family business alongside Sam, Edoardo and the broader Lauxera team.
Dr. Andreas & Kirsi SchuesslerCo-Founders of Acandis
”We’re excited to work together with Lauxera Capital Partners, leveraging their expertise to fulfill Natural Cycles’ mission of making hormone-free birth control more accessible and combining technology and science to fill the gaps in underserved areas of women’s health.
Dr. Raoul ScherwitzlCo-Founder and CEO of Natural Cycles
”The Lauxera team have helped us build US presence, scale our operations and grow our business organically, while delivering positive EBITDA. They possess deep knowledge, strategic flair, urgency to drive business expansion and are not afraid to roll up their sleeves to help get it done.
Klaus Langhoff-RoosCEO at BioLamina
”Our relationship with Lauxera, built on robust mutual trust, has been a strong asset in developing a growth strategy, strengthening our global leadership, reinforcing our presence in North America, Europe and Asia. What we value most about Lauxera is their hands on attitude, the seniority of their leadership, the deep knowledge of the biopharma industry and their extensive network.
Charles RubanCEO at Verdot
”We are pleased to work with Lauxera, a specialist Healthtech investor with great capabilities and experience in Healthtech software and North American scale up, to support and accelerate the growth of our business.
Jérémy WiesCo-founder and President of Synovo
”Lauxera is a business accelerator! The team has been instrumental in providing an outstanding M&A expertise, from screening opportunities on the market to closing two key acquisitions for Ospi. They have a great expertise in the health field, and they give access to their relevant network. And last but not least, we have a relationship of trust!
Jean-Baptiste AngeloglouCEO at OSPI
”Lauxera is exceptional in its entrepreneurial approach as an investor for our business, always available, always responsive and providing meaningful and real support on an ongoing base.
Hugo de WitCEO at Lumicks
